BMEA A2A Pharmaceuticals, Inc. sold Biomea Fusion, Inc. shares — SEC Form 4SELLBiomea Fusion, Inc.

A2A Pharmaceuticals, Inc., 10% Owner at Biomea Fusion, Inc. (BMEA), sold 200,000 shares at $31.25 ($6.3M) on 2023-03-31, disclosed to the SEC on 2023-04-06.